Dendrites cells activated by malignant stem cells antigens - technology of a new generation oncovaccine development

A. V. Bersenev

Genes & Cells ›› 2007, Vol. 2 ›› Issue (1) : 15 -17.

Genes & Cells ›› 2007, Vol. 2 ›› Issue (1) : 15 -17.
Cell technology
brief-report

Dendrites cells activated by malignant stem cells antigens - technology of a new generation oncovaccine development

Author information +
History +

Abstract

Cite this article

Download citation ▾
A. V. Bersenev. Dendrites cells activated by malignant stem cells antigens - technology of a new generation oncovaccine development. Genes & Cells, 2007, 2(1): 15-17 DOI:

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Banchereau J., Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 2005; 5(4): 296-306.

[2]

Nestle F.O., Farkas A., Conrad C. Dendritic-cell-based therapeutic vaccination against cancer. Curr. Opin. Immunol. 2005; 17(2): 163-9.

[3]

Dalerba P., Cho R.W., Clarke M.F. Cancer Stem Cells: Model and Concepts. Annu. Rev. Med. 2007; 58: 18.1 -18.18.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap

148

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/